Last reviewed · How we verify
data report
At a glance
| Generic name | data report |
|---|---|
| Also known as | gliptin |
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
- Facilitating Opioid Care Connections (NA)
- Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial (NA)
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials (NA)
- Speech-to-text Tool for Heart Failure Patient-Reported Data (NA)
- Palliative Care for People With HF
- NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
- Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |